Skip to content

A STUDY OF EXTERNAL THERAPY (VARMA THADAVAL) FOR LUMBAR SPONDYLOSIS

AN OPEN CLINICAL TRIAL ON VARMA THADAVAL (VARMA MANIPULATION TECHNIQUE) WITH MUKKOOTTU ENNAI IN THE MANAGEMENT OF THANDAGAVATHAM (LUMBAR SPONDYLOSIS)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/043942
Enrollment
30
Registered
2022-07-12
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M472- Other spondylosis with radiculopathy

Interventions

Intervention1: Varma Thadaval(Physical Manipulation)with Mukkoottu Ennai (Medicated Oil): Physical manipulation with dermal application of sufficient Quantity of Mukkoottu Ennai once in a week for 48

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with two or more clinical features of the following: a) Pain in the lumbar region and the pain increased in forward bending b) Radiating pain to buttocks and lower limbs c) Stiffness in the lumbar region d) Exacerbation of pain on movements e) Tingling sensation (Numbness present in the lower limb) 2. Grade I & II - Degenerative condition in lumbar spine 3. Patients who are willing to give radiological investigation and provide blood for lab investigation. 4. Patient willing to sign the informed consent stating that he/she will conscientiously stick to the treatment during 48 days but can opt-out of the trail of his/her own conscious discretion.

Exclusion criteria

Exclusion criteria: H/o Cardiac diseases • H/o Autoimmune diseases • H/o Renal Diseases • H/o Spinal deformities • H/o Ankylosing spondylitis • Traumatic history of the spine • Tuberculosis and other infections in the spine • Pregnancy women and lactating mothers • Patient with any other serious systemic illness

Design outcomes

Primary

MeasureTime frame
The outcome of this study will be using The Visual Analogue assessment scale (before and after treatment)Timepoint: Screening - 2 months Enrolment - 2 months Treatment - 4 months Data Analysis - 2 months Follow up - 2 months

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr V Mahalakshmi MD PhD

National Institute of Siddha

rvmahalakshmi85@gmail.com9940668576

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026